← FDA Drug Approvals (Drugs@FDA)

CITALOPRAM HYDROBROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2006-10-03

Drug application

FDA Application #

ANDA077534

Application type

Abbreviated New Drug Application (Generic)

Brand name

CITALOPRAM HYDROBROMIDE

Generic name

CITALOPRAM

Active ingredients

CITALOPRAM HYDROBROMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Cipla USA Inc.

First approval

2006-10-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown